The phosphatidylinositol 3-kinase (PI3K)/AKT/mTOR signaling pathway, which drives cell proliferation, motility, and survival, is frequently hyperactivated in a variety of malignancies [6, 7], and inhibition of this pathway has been considered an appropriate approach for cancer therapy. The gene discussed is AKT1; the disease is cancer.